erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
� 2018 nbc universal
.
share on linkedin linkedin
.
"it's a very exciting time," klugman said. "this is exactly where we would like prenatal diagnosis to go -- to be able to act on it."
.
when his patients ask how long they’ll be at the hospital with a procedure like this, he tries to manage their expectations.
.globally 25mn unsafe abortions take place every year: report
.
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
he has worked with patients under similar circumstances, but is not involved in the first lady’s case.
.
.